novo semaglutide alzheimer's Oxord study says Nordisk's Ozempic can cut risk of dementia Ozempic, Wegovy Might Help Lower

Comparing yourself to trial averages can mislead because trial participants typically receive intensive dietary counseling, regular monitoring, and support that real-world users lack

35,36 While the subsequent GUIDE-HF trial did not find a difference in cardiovascular outcomes using PA pressure monitoring, a newly published trial based out of Europe, MONITOR-HF, demonstrated findings similar to the earlier CHAMPION trial that PA pressure monitoring to guide HF management reduced HF-related hospitalizations and improved quality of life

This kind of preclinical model is invaluable

The genomics of undifferentiated sarcoma of soft tissue: progress, challenges and opportunities